EMVision Appoints Prof Alan Coulthard To Clinical Advisory Board
EMVision Medical Devices Limited (ASX:EMV) (“EMVision” or the “Company”), is pleased to announce the appointment of a leader in the field of medical imaging and stroke care, Professor Alan Coulthard, to EMVision’s Clinical Advisory Board.
Alan is Professor of Neuroradiology at the University of Queensland and a full-time Senior Staff Specialist in diagnostic and interventional neuroradiology at the Royal Brisbane and Women’s Hospital. He is Director of Research for the Department of Medical Imaging with an emphasis on mentoring junior doctors in research. He has over 35 years of experience in medical imaging and 20 years experience in the endovascular treatment of cerebrovascular diseases including ischaemic stroke.
His research interests and collaborations have included neurodegenerative disease, neuroncology, neurovascular disease, neurointervention, epilepsy, neonatal imaging and multiple sclerosis. He has a National leadership profile, having served as President of ANZSNR, inaugural chair of CCINR and in many roles for RANZCR, stepping down from the Board of Directors at the end of 2022.
Professor Alan Coulthard commented: “Effective stroke intervention requires efficient and robust patient selection with minimal delay to treatment. This technology will lead to better outcomes for a larger geographical range of stroke patients in Australia and internationally.”
EMVision CEO, Dr Ron Weinberger commented: “Alan will bring further insight and skills to our already impressive clinical team to ensure that we are developing a fit for purpose commercial product. His willingness to come on board reflects the support that exists to treat stroke in the most timely and urgent way possible”
Professor Alan Coulthard’s appointment is an unsalaried position. EMVision
